GB0310981D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
GB0310981D0
GB0310981D0 GBGB0310981.6A GB0310981A GB0310981D0 GB 0310981 D0 GB0310981 D0 GB 0310981D0 GB 0310981 A GB0310981 A GB 0310981A GB 0310981 D0 GB0310981 D0 GB 0310981D0
Authority
GB
United Kingdom
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0310981.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GBGB0310981.6A priority Critical patent/GB0310981D0/en
Publication of GB0310981D0 publication Critical patent/GB0310981D0/en
Priority to CL200401008A priority patent/CL2004001008A1/en
Priority to PCT/EP2004/005080 priority patent/WO2004101584A1/en
Priority to ARP040101612A priority patent/AR044307A1/en
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
GBGB0310981.6A 2003-05-13 2003-05-13 Novel compounds Ceased GB0310981D0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GBGB0310981.6A GB0310981D0 (en) 2003-05-13 2003-05-13 Novel compounds
CL200401008A CL2004001008A1 (en) 2003-05-13 2004-05-11 COMPOUNDS DERIVED FROM MACROLIDS OF 14 OR 15 MEMBERS, REPLACED IN POSITION 3; PROCEDURE FOR PREPARATION; PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS IT; AND ITS USE FOR THE TREATMENT OR PROFILAXIS OF SYSTEMIC OR TOPIC MICROBIAL INFECTIONS
PCT/EP2004/005080 WO2004101584A1 (en) 2003-05-13 2004-05-11 Macrolides substituted at the 3-position having antimicrobial activity
ARP040101612A AR044307A1 (en) 2003-05-13 2004-05-11 MACROLID COMPOUND OF 14 AND 15 MEMBERS REPLACED IN POSITION 3, PROCEDURE FOR THE PREPARATION OF THE SAME, ITS USE FOR THE MANUFACTURE OF A MEDICINAL PRODUCT AND PHARMACEUTICAL COMPOSITION THAT INCLUDES IT

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0310981.6A GB0310981D0 (en) 2003-05-13 2003-05-13 Novel compounds

Publications (1)

Publication Number Publication Date
GB0310981D0 true GB0310981D0 (en) 2003-06-18

Family

ID=9957981

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0310981.6A Ceased GB0310981D0 (en) 2003-05-13 2003-05-13 Novel compounds

Country Status (4)

Country Link
AR (1) AR044307A1 (en)
CL (1) CL2004001008A1 (en)
GB (1) GB0310981D0 (en)
WO (1) WO2004101584A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009019868A1 (en) 2007-08-06 2009-02-12 Taisho Pharmaceutical Co., Ltd. 10a-azalide compound crosslinked at position-10a and position-12
WO2009139181A1 (en) 2008-05-15 2009-11-19 大正製薬株式会社 10a-azalide compound having 4-membered ring structure

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA989835B (en) * 1997-10-29 1999-05-05 Taisho Pharmaceutical Co Ltd Erythromycin a derivatives
US20020115621A1 (en) * 2000-08-07 2002-08-22 Wei-Gu Su Macrolide antibiotics

Also Published As

Publication number Publication date
AR044307A1 (en) 2005-09-07
WO2004101584A1 (en) 2004-11-25
CL2004001008A1 (en) 2005-03-18

Similar Documents

Publication Publication Date Title
GB0308114D0 (en) Novel compounds
GB0305918D0 (en) Novel compounds
GB0308185D0 (en) Novel compounds
GB0308186D0 (en) Novel compounds
GB0304424D0 (en) Novel compounds
EP1596860A4 (en) Novel compounds
EP1648885A4 (en) Novel compounds
GB0305426D0 (en) Novel compounds
GB0302431D0 (en) Novel compounds
GB0304809D0 (en) Novel compounds
GB0302546D0 (en) Novel compounds
GB0310981D0 (en) Novel compounds
EP1635834A4 (en) Novel compounds
GB0304803D0 (en) Novel compounds
GB0301592D0 (en) Novel compounds
GB0303467D0 (en) Novel compounds
GB0303464D0 (en) Novel compounds
GB0302988D0 (en) Novel compounds
GB0304802D0 (en) Novel compounds
GB0305586D0 (en) Novel compounds
GB0305564D0 (en) Novel compounds
GB0308187D0 (en) Novel compounds
GB0304811D0 (en) Novel compounds
GB0305687D0 (en) Novel compounds
GB0305163D0 (en) Novel compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)